PriceTargets.com logo

OTCMKTS:MHIVF - Invesque Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $1.25
  • Forecasted Upside: 0.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.25 As of 08/9/2022 01:00 AM ET
▲ +0.05 (4.17%)

This chart shows the closing price for MHIVF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Invesque Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MHIVF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MHIVF

Analyst Price Target is $1.25
This price target is based on 0 analysts offering 12 month price targets for Invesque in the last 3 months. The average price target is $1.25, with a high forecast of $1.25 and a low forecast of $1.25. The average price target represents a 0.00% upside from the last price of $1.25.

This chart shows the closing price for MHIVF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Invesque. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
5/17/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
8/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
11/13/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
2/11/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/11/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/10/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/20/2022National Bank FinancialLower Price TargetC$1.75 ➝ C$1.25
7/19/2021National Bank FinancialLower Price TargetSector PerformC$3.00 ➝ C$2.75
4/23/2021National Bank FinancialReiterated RatingSector Perform
4/1/2021BMO Capital MarketsReiterated RatingOutperform ➝ Market Perform$2.75 ➝ $2.50
3/26/2021BMO Capital MarketsDowngradeOutperform ➝ Market Perform$2.75 ➝ $2.50
3/16/2020CIBCDowngradeHold$5.50
(Data available from 8/10/2017 forward)

News Sentiment Rating

-0.17 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/12/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/11/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/13/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/12/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/12/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/11/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/11/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/10/2022

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

  • No very positive mentions tracked during this time.
Invesque logo
Invesque Inc. operates as a health care real estate investment company. Its portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2022, the company owned a portfolio of 88 properties, including 60 assisted living and memory care facilities, 12 skilled nursing facilities, 10 transitional care properties, and 4 medical office buildings in the United States; and 15 properties comprised 11 medical office buildings, and 4 seniors housing and care facilities in Canada. It also includes investments in owner occupied seniors housing properties, which comprise the ownership of real estate properties, as well as provides management services. The company was formerly known as Mainstreet Health Investments Inc. and changed its name to Invesque Inc. in January 2018. Invesque Inc. was incorporated in 2007 and is headquartered in Toronto, Canada.
Read More

Today's Range

Now: $1.25
Low: $1.20
High: $1.25

50 Day Range

MA: $1.21
Low: $1.06
High: $1.35

52 Week Range

Now: $1.25
Low: $0.75
High: $2.65

Volume

28,449 shs

Average Volume

7,835 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Invesque?

The following Wall Street research analysts have issued reports on Invesque in the last year: National Bank Financial.
View the latest analyst ratings for MHIVF.

What is the current price target for Invesque?

1 Wall Street analysts have set twelve-month price targets for Invesque in the last year. Their average twelve-month price target is $1.25. National Bank Financial has the highest price target set, predicting MHIVF will reach $1.25 in the next twelve months. National Bank Financial has the lowest price target set, forecasting a price of $1.25 for Invesque in the next year.
View the latest price targets for MHIVF.

What is the current consensus analyst rating for Invesque?

Invesque currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MHIVF.

What other companies compete with Invesque?

Other companies that are similar to Invesque include CareRx, Field Trip Health, Greenbrook TMS, Greenbrook TMS and JD Health International. Learn More about companies similar to Invesque.

How do I contact Invesque's investor relations team?

Invesque's physical mailing address is 333 Bay Street, Toronto, ON M5H. The company's listed phone number is (317) 643-4017. The official website for Invesque is invesque.com. Learn More about contacing Invesque investor relations.